Literature DB >> 18796655

What are the risks--hypothetical and observed--of recombination involving live vaccines and vaccine vectors based on nonsegmented negative-strain RNA viruses?

Peter L Collins, Alexander Bukreyev, Brian R Murphy.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18796655      PMCID： PMC2546970          DOI： 10.1128/JVI.01336-08

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


× No keyword cloud information.
  20 in total

1.  Phylogenetic analysis reveals a low rate of homologous recombination in negative-sense RNA viruses.

Authors:  Elizabeth R Chare; Ernest A Gould; Edward C Holmes
Journal:  J Gen Virol       Date:  2003-10       Impact factor: 3.891

2.  Caution about Newcastle disease virus-based live attenuated vaccine.

Authors:  Guan-Zhu Han; Xi-Ping Liu; Si-Shen Li
Journal:  J Virol       Date:  2008-07       Impact factor: 5.103

3.  Genetic variability in envelope-associated protein genes of closely related group A strains of respiratory syncytial virus.

Authors:  H Zheng; G A Storch; C Zang; T C Peret; C S Park; L J Anderson
Journal:  Virus Res       Date:  1999-01       Impact factor: 3.303

4.  Genetic recombination during coinfection of two mutants of human respiratory syncytial virus.

Authors:  Kirsten M Spann; Peter L Collins; Michael N Teng
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

5.  Pathogen evolution and disease emergence in carnivores.

Authors:  Alex J McCarthy; Marie-Anne Shaw; Simon J Goodman
Journal:  Proc Biol Sci       Date:  2007-12-22       Impact factor: 5.349

6.  A paramyxovirus-vectored intranasal vaccine against Ebola virus is immunogenic in vector-immune animals.

Authors:  Lijuan Yang; Anthony Sanchez; Jerrold M Ward; Brian R Murphy; Peter L Collins; Alexander Bukreyev
Journal:  Virology       Date:  2008-08-01       Impact factor: 3.616

7.  F gene recombination between genotype II and VII Newcastle disease virus.

Authors:  Zhuoming Qin; Lei Sun; Baochen Ma; Zhizhong Cui; Yiping Zhu; Yoshihiro Kitamura; Wenjun Liu
Journal:  Virus Res       Date:  2007-11-19       Impact factor: 3.303

8.  Isolates of Zaire ebolavirus from wild apes reveal genetic lineage and recombinants.

Authors:  Tatiana J Wittmann; Roman Biek; Alexandre Hassanin; Pierre Rouquet; Patricia Reed; Philippe Yaba; Xavier Pourrut; Leslie A Real; Jean-Paul Gonzalez; Eric M Leroy
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-17       Impact factor: 11.205

Review 9.  Newcastle disease virus as a vaccine vector for humans.

Authors:  Alexander Bukreyev; Peter L Collins
Journal:  Curr Opin Mol Ther       Date:  2008-02

10.  Cross-species recombination in the haemagglutinin gene of canine distemper virus.

Authors:  Guan-Zhu Han; Xi-Ping Liu; Si-Shen Li
Journal:  Virus Res       Date:  2008-06-11       Impact factor: 3.303
View more
  14 in total

Review 1.  Reverse genetics of Mononegavirales: How they work, new vaccines, and new cancer therapeutics.

Authors:  Christian K Pfaller; Roberto Cattaneo; Matthias J Schnell
Journal:  Virology       Date:  2015-02-18       Impact factor: 3.616

2.  Newcastle disease virus-vectored vaccines expressing the hemagglutinin or neuraminidase protein of H5N1 highly pathogenic avian influenza virus protect against virus challenge in monkeys.

Authors:  Joshua M DiNapoli; Baibaswata Nayak; Lijuan Yang; Brad W Finneyfrock; Anthony Cook; Hanne Andersen; Fernando Torres-Velez; Brian R Murphy; Siba K Samal; Peter L Collins; Alexander Bukreyev
Journal:  J Virol       Date:  2009-11-18       Impact factor: 5.103

3.  Respiratory tract immunization of non-human primates with a Newcastle disease virus-vectored vaccine candidate against Ebola virus elicits a neutralizing antibody response.

Authors:  Joshua M DiNapoli; Lijuan Yang; Siba K Samal; Brian R Murphy; Peter L Collins; Alexander Bukreyev
Journal:  Vaccine       Date:  2010-10-27       Impact factor: 3.641

4.  RNA replicons - a new approach for influenza virus immunoprophylaxis.

Authors:  Gert Zimmer
Journal:  Viruses       Date:  2010-01-29       Impact factor: 5.818

Review 5.  Homologous recombination in negative sense RNA viruses.

Authors:  Guan-Zhu Han; Michael Worobey
Journal:  Viruses       Date:  2011-08-04       Impact factor: 5.048

6.  Development of a helper cell-dependent form of peste des petits ruminants virus: a system for making biosafe antigen.

Authors:  Jana Baron; Michael D Baron
Journal:  Vet Res       Date:  2015-09-23       Impact factor: 3.683

7.  Protective efficacy of Newcastle disease virus expressing soluble trimeric hemagglutinin against highly pathogenic H5N1 influenza in chickens and mice.

Authors:  Lisette A H M Cornelissen; Olav S de Leeuw; Mirriam G Tacken; Heleen C Klos; Robert P de Vries; Els A de Boer-Luijtze; Diana J van Zoelen-Bos; Alan Rigter; Peter J M Rottier; Rob J M Moormann; Cornelis A M de Haan
Journal:  PLoS One       Date:  2012-08-28       Impact factor: 3.240

Review 8.  Developing Universal Influenza Vaccines: Hitting the Nail, Not Just on the Head.

Authors:  Lidewij C M Wiersma; Guus F Rimmelzwaan; Rory D de Vries
Journal:  Vaccines (Basel)       Date:  2015-03-26

Review 9.  Unique safety issues associated with virus-vectored vaccines: Potential for and theoretical consequences of recombination with wild type virus strains.

Authors:  Richard C Condit; Anna-Lise Williamson; Rebecca Sheets; Stephen J Seligman; Thomas P Monath; Jean-Louis Excler; Marc Gurwith; Karin Bok; James S Robertson; Denny Kim; R Michael Hendry; Vidisha Singh; Lisa M Mac; Robert T Chen
Journal:  Vaccine       Date:  2016-06-23       Impact factor: 3.641

10.  Comparison of the Immunogenicities and Cross-Lineage Efficacies of Live Attenuated Peste des Petits Ruminants Virus Vaccines PPRV/Nigeria/75/1 and PPRV/Sungri/96.

Authors:  Michael D Baron; Karin E Darpel; Sophia Hodgson; Katy Moffat; Holly Hill; John T Flannery; Simon P Graham
Journal:  J Virol       Date:  2018-11-27       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.